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pacted elastic fibers. The intima and adventitia were not usu-
ally involved (Fig 1).
Results
Patient characteristics (Table I). Of the 19 patients, 12 were
women, and 6 were men. The mean age at the time of surgi-
cal repair was 73.2 years (range, 41-85 years).
Clinical symptoms and clinical course.  The most common
clinical symptoms were dyspnea on exertion (11/19) and angi-
na (6/19).
Symptoms referable to the cranial arteries, such as scalp
tenderness, jaw claudication, extremity claudication, vision
loss, or temporal artery tenderness were not mentioned. The
mean duration of onset of symptoms was approximately 2.2
years.
The most common physical finding consisted of a new mur-
mur (14/19), with aortic insufficiency confirmed in 9 of 19
patients by echocardiography, cardiac catheterization, or both.
Hypertension was present in 6 of 19 patients during the peri-
operative period. Sedimentation rates were not obtained in
any patient. All aneurysms were classified preoperatively as
atherosclerotic.
At the time of surgery, 17 of 19 had thoracic aortic
aneurysms involving the ascending portion of the aorta. Two
of these patients had acute dissection. Six of 19 had
aneurysms of both the thoracic and abdominal aortas, and 2 of
19 had aneurysms of the abdominal aorta alone. Of the 9 aor-
tic valves replaced, none had valvulitis. All patients had resec-
tion of the aneurysm and graft placement. No mention was
made of any unusual gross operative findings indicative of
giant cell aortitis at the time of surgery. There was no postop-
erative mortality, and all patients were discharged home with-
out the use of steroids or immunosuppressive agents, because
the importance of the histopathology was not appreciated and
rheumatologic consultations were not sought.
Follow-up and outcome. The duration of follow-up varied
from 1 to 4 years. During this period, there were two sudden
deaths. The exact cause of death, however, could not be ascer-
tained in either case. Nine patients are alive; of these, two are
symptomatic.
Discussion. These 19 cases of tissue-documented active
giant cell aortitis necessitating surgical intervention define a
subgroup of patients with GCA whose active aortitis affecting
the thoracic aorta is clinically occult, who lack symptoms
referable to the cranial arteries, who have no history of tem-
poral arteritis, and whose outcomes may be catastrophic.
Our experience is similar to that of previous authors.
Brack and colleagues3 described two clinical patterns of
Although giant cell arteritis (GCA) affecting the aorta has
been well described, its incidence as a complication of tem-
poral arteritis has been considered infrequent.1 Aortic dissec-
tion and aneurysm rupture were noted as rare, catastrophic
sequelae occurring in patients with a previously established
diagnosis of temporal arteritis2 who had symptoms referable
to the cranial arteries or upper extremity claudication. 
In contrast, we describe 19 patients who presented, over a
4-year period, with thoracic aneurysms, abdominal
aneurysms, or both, caused by active giant cell aortitis docu-
mented histopathologically. Only one patient had a history of
temporal arteritis before aortic repair. The others lacked vas-
cular symptoms.
Our experience suggests that active aortitis caused by occult
GCA occurs more commonly than has been previously appre-
ciated and may represent an important clinical variant of this
disease. Efforts to improve recognition of giant cell aortitis to
define optimal treatment strategies are warranted.
Patients and methods. A total of 1069 cases of aortic
aneurysm repair or replacement performed between 1994 and
1998 were reviewed, in which 19 cases of active giant cell
aortitis confirmed histopathologically were identified. All tis-
sues reviewed were obtained at the time of surgery and were
routinely processed for hematoxylin and eosin staining, as
well as Gram staining, acid-fast staining, and fungal staining.
The pathologic diagnosis of GCA was based on the finding of
focal areas of medial necrosis surrounded by a granuloma-
tous-like inflammatory reaction. Occasional multinucleated
giant cells were present at the periphery of the necrotic areas.
The necrotic areas were devoid of cells and contained com-
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GCA consisting of cranial arteritis and large-vessel GCA.
Their subgroup of patients with large-vessel disease had
upper-extremity claudication or cardiovascular symptoms
only. Evans and colleagues1 described a markedly
increased incidence of thoracic aortic aneurysms in their
cohort of patients with biopsy-proven GCA compared with
an age-matched population. Liu and colleagues,4 in a
review of 24 patients with thoracic aortic dissection caused
by giant cell aortitis documented histopathologically, found
that 11 of 24 had no prior symptoms of temporal arteritis
and received no diagnosis until their catastrophic illness.
Lie5 described 72 patients with biopsy- or autopsy-docu-
mented active giant cell aortitis or extracranial GCA.
Twenty-five percent of these patients had no symptoms
referable to the cranial arteries. At surgery or autopsy,
active giant cell aortitis affecting the aortic arch and
ascending aorta predominated in 39%, which is similar to
what we found in our patients. 
Although incomplete, our follow-up data are suggestive of
a poor outcome subsequent to successful surgical repair.
Because GCA is a systemic disease, it is unlikely that aortic
repair, although life-saving in the short term, is curative.
Unfortunately, despite histopathologic documentation of
active aortitis rather than atherosclerosis alone, none of these
patients received either steroids or immunosuppressive thera-
py because the importance of the histopathology document-
ing active vasculitis was not appreciated, and rheumatologic
input was not obtained.
Further study is required to define the optimal immuno-
suppressive regimen and is dependent on improved recog-
nition of aortitis by the surgeons involved in these patients’
care.
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Table I. Clinical characteristics of 19 patients with giant cell aortitis
Patient .Age Cardiovascular Blood pressure New
No (y) Sex symptoms (mm Hg) murmur
1 41 F Angina 106/60 +
2 74 M CHF, angina NR –
3 83 F CHF, angina, palpitations 150/90 +
4 66 F None 100/78 +
5 65 F CHF, angina, palpitations 160/68 +
6 76 M CHF 130/58 +
7 77 F CHF NR +
8 79 F CHF, angina 162/100 +
9 80 M CHF 116/60 +
10 80 F None 140/70 +
11 81 F CHF 130/80 +
12 78 M None 146/70 +
13 85 M CHF 150/70 +
14 75 F CHF, angina 140/50 –
15 72 F None 121/74 –
16 74 M None 140/90 –
17 63 F Palpitations 150/80 –
18 68 M None 102/52 +
19 74 F CHF 142/98 +
descend, Descending aorta; F, fusiform; NR, Not recorded; CHF, congestive heart failure; ascend, ascending aorta; S, saccular.
Fig 1.  Tissue obtained from patient 1, demonstrating giant cell aortitis. A, Active aortitis. Arrow identifies a giant
cell. (Hematoxylin and eosin stain; original magnification 200×.) B, Giant cell aortitis with a large area of necro-
sis. (Hematoxylin and eosin stain; original magnification 100×.)
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Hemoglobin Location of Aortic insufficiency/ Acute Outcome
level (mg/dL) aneurysms and type aortic valve replacement dissection (1-4 y postoperative)
12.3 Descend (F) – – NR
11.9 Arch, ascend, descend (F) – + Alive
13.0 Arch, ascend (F) – – NR
14.0 Ascend (F) + – Alive
12.3 Ascend (F) + – Alive
13.9 Ascend (F) + – Alive
11.7 Ascend (F) + – NR
9.9 Arch, ascend, descend (S) + – NR
10.1 Ascend (F) – – Dead
NR Ascend (F) + – NR
14.1 Arch, ascend, descend (F) – – Alive
13.8 Ascend (F) + + NR
14.7 Arch, ascend (F) + – Alive
13.4 Ascend (F) – – Alive
10.5 Arch, ascend, descend (F) – – Alive
14.3 Arch, ascend, descend (F) – – NR
13.0 Descend (NR) – – Alive
14.3 Arch, ascend, descend (F) + – Dead
13.0 Arch, ascend (F) – – Alive
